LB Pharmaceuticals Inc

1 Penn Plz Ste 1025
New York, NY 10119

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in New York, NY, focused on developing novel therapies for the treatment of neuropsychiatric diseases, including schizophrenia and bipolar depression. The company's lead product candidate, LB102, is positioned to potentially become the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States.

The firm is actively building a pipeline that leverages the broad therapeutic potential of LB102, informed by peer-reviewed research and presentations. As LB Pharmaceuticals Inc advances its clinical efforts, it seeks to address unmet needs in mental health treatment through innovative approaches.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesNew YorkNew YorkLB Pharmaceuticals Inc

Partial Data by Infogroup (c) 2025. All rights reserved.